Frequently Asked Questions

Who creates AACE Endocrine AI content?

AACE Endocrine AI is produced by Conexiant in collaboration with the American Association of Clinical Endocrinology (AACE). Most content is developed by an independent editorial team, with input and guidance from AACE-affiliated clinicians. Contributions may also come from endocrinologists, researchers, and experts in artificial intelligence and digital health.

What is Conexiant?

Conexiant is a medical media and education company that develops specialty-focused publications, including AACE Endocrine AI.

Who is AACE Endocrine AI for?

AACE Endocrine AI is designed for endocrinologists, diabetes specialists, advanced practice providers, researchers, data scientists, and health system leaders interested in the role of artificial intelligence and emerging technologies in endocrine care.

How does AACE Endocrine AI use artificial intelligence?

AACE Endocrine AI incorporates AI tools—with human editorial oversight—to support content development, including summarization, formatting, and multimedia enhancements such as audio or brief digests. All content is reviewed by qualified editors to ensure clinical accuracy and clarity.

How does AACE Endocrine AI address bias and limitations in AI?

AACE Endocrine AI actively examines the challenges associated with artificial intelligence, including bias, data limitations, and variability in model performance. Coverage emphasizes transparency, validation, and equitable implementation of AI in endocrine practice.

Is AACE Endocrine AI available in print?

No. AACE Endocrine AI is a digital-first platform, allowing for timely updates and evolving coverage as the field advances.

Is content peer-reviewed?

AACE Endocrine AI content is reviewed by an editorial team for accuracy, relevance, and clarity, but it does not undergo formal peer review.